SCINAI IMMUNOTHERAPEUTICS LTD. Operating Lease, Right-of-Use Asset, Amortization Expense
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $153.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2023-04-17
- SCINAI IMMUNOTHERAPEUTICS LTD. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $153.00K, a 3.38% increase from fiscal 2021.
- SCINAI IMMUNOTHERAPEUTICS LTD. operating lease, right-of-use asset, amortization expense for fiscal 2021 was $148.00K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|
| 2022-12-31 | $153.00K 10-K · filed 2023-04-17 |
| 2021-12-31 | $148.00K 10-K · filed 2023-04-17 |